[1] 唐神结, 沙巍, 肖和平, 等. 非结核分枝杆菌病的研究进展[J]. 中华结核和呼吸杂志, 2012,35(7):527-531. [2] 孙勤, 沙巍. 非结核分枝杆菌肺病与肺结核患者的临床特征对比分析[J]. 中国防痨杂志, 2011,33(2):120-122. [3] 全国结核病流行病学抽样调查技术指导组. 第四次全国结核病流行病学抽样调查报告[J]. 中华结核和呼吸杂志, 2002,25(1):3-7. [4] 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告[J]. 中国防痨杂志, 2012,34(8):485-508. [5] 段鸿飞, 土井教生, 李琦, 等. 鸟分枝杆菌复合群对16种抗感染药物药敏试验的分析[J]. 中华结核和呼吸杂志, 2010,33(5):359-362. [6] INDERLIED CB, KEMPER CA, BERMUDEZ LE. The Mycobacterium avium complex[J]. ClinMicrobiol Rev, 1993,6(3):266-310. [7] HAN XY, TARRAND JJ, INFANTE R, et al. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS[J]. J Clin Microbiol, 2005,43(9):4407-4412. [8] UCHIYA K, TAKAHASHI H, YAGI T, et al. Comparative genome analysis of Mycobacterium avium revealed genetic diversity in strains that cause pulmonary and disseminated disease[J]. Plos One, 2013,8(8):e71831. [9] DOUCET-POPULAIRE F, BURIANKOVA K, WEISER J, et al. Natural and acquired macrolide resistance in mycobacteria[J]. Curr Drug Targets Infect Disord, 2002,2(4):355-370. [10] UCHIYA K, TAKAHASHI H, YAGI T, et al. Comparative genome analysis of Mycobacterium avium revealed genetic diversity in strains that cause pulmonary and disseminated disease[J]. Plos One, 2013,8(8):e71831. [11] KOH E, IIZASA T, YAMAJI H, et al. Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer[J]. Int J Surg Pathol, 2012,20(3):233-239. [12] JI B, LOUNIS N, TRUFFOT-PERNOT C, et al. Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy[J]. Antimicrob Agents Chemother, 1992,36(12):2839-2840. [13] MEIER A, KIRSCHNER P, SPRINGER B, et al. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare[J]. Antimicrob Agents Chemother, 1994,38(2):381-384. [14] SCHMALSTIEG AM, SRIVASTAVA S, BELKAYA S, et al. The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance[J]. Antimicrob Agents Chemother, 2012,56(9):4806-4815. |